| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-23725SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-56432SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-26680-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-82120-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-82145-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-21529-50ul | |||
![Immunohistochemistry-Paraffin: Dtk/TYRO3 Antibody [NBP2-23725] - Analysis of TYRO3 in paraffin-embedded formalin-fixed human liver tissue using an isotype control (top) and this antibody (bottom) at 1:100.](http://images.novusbio.com/fullsize/Dtk-TYRO3-Antibody-Immunohistochemistry-Paraffin-NBP2-23725-img0002.jpg "Immunohistochemistry-Paraffin: Dtk/TYRO3 Antibody [NBP2-23725] - Analysis of TYRO3 in paraffin-embedded formalin-fixed human liver tissue using an isotype control (top) and this antibody (bottom) at 1:100.")
![Western Blot: MLK4 Antibody [NBP1-41081] - Total MLK4 expression in breast cancer cells. Image from verified customer review.](http://images.novusbio.com/fullsize/MLK4-Antibody-Western-Blot-NBP1-41081-img0003.jpg "<b>Biological Strategies Validation. </b>Western Blot: MLK4 Antibody [NBP1-41081] - Total MLK4 expression in breast cancer cells. Image from verified customer review.")
![<b>Independent Antibodies Validation and Biological Strategies Validation.</b>Western Blot: MLK4 Antibody [NBP1-41081] - Whole cell lysate from HeLa (5, 15 and 50 ug for WB; 1 mg for IP, 20% of IP loaded) and 293T (T; 50 ug) cells. Antibodies: Affinity purified rabbit antiMLK4 antibody NBP1-41081 used for WB at 0.04 ug/ml (A) and 1 ug/ml (B) and used for IP at 3 ug/mg lysate. MLK4 was also immunoprecipitated by rabbit anti-MLK4 antibody NBP1-41080, which recognizes an upstream epitope.](http://images.novusbio.com/fullsize/MLK4-Antibody-Western-Blot-NBP1-41081-img0002.jpg)
![Western Blot: PIM2 Antibody [NBP1-33731] - Sample (30 ug of whole cell lysate) A: 293T 10% SDS PAGE; antibody diluted at 1:1000.](http://images.novusbio.com/fullsize/PIM2-Antibody-Western-Blot-NBP1-33731-img0004.jpg "Western Blot: PIM2 Antibody [NBP1-33731] - Sample (30 ug of whole cell lysate) A: 293T 10% SDS PAGE; antibody diluted at 1:1000.")
![Immunohistochemistry-Paraffin: PIM2 Antibody [NBP1-33731] - Paraffin-embedded Breast ca, using antibody at 1:250 dilution.](http://images.novusbio.com/fullsize/PIM2-Antibody-Immunohistochemistry-Paraffin-NBP1-33731-img0003.jpg)
![Western Blot: PIM2 Antibody [NBP1-33731] - PIM2 antibody detects PIM2 protein by Western blot analysis.A. 50 ug mouse testis lysate/extract 12 % SDS-PAGEPIM2 antibody (NBP1-33731) dilution: 1:500](http://images.novusbio.com/fullsize/nbp1-33731_rabbit-polyclonal-pim2-antibody-9102024205610.jpg)
![Western Blot: BMPR-II Antibody [NBP1-32218] - Wild-type (WT) and BMPR2 knockout (KO) HeLa cell extracts (30 ug) were separated by 5% SDS-PAGE, and the membrane was blotted with BMPR2 antibody diluted at 1:500. HRP-conjugated anti-rabbit IgG antibody was used to detect the primary antibody.](http://images.novusbio.com/fullsize/BMPR-II-Antibody-Western-Blot-NBP1-32218-img0003.jpg "<b>Genetic Strategies Validation. </b>Western Blot: BMPR-II Antibody [NBP1-32218] - Wild-type (WT) and BMPR2 knockout (KO) HeLa cell extracts (30 ug) were separated by 5% SDS-PAGE, and the membrane was blotted with BMPR2 antibody diluted at 1:500. HRP-conjugated anti-rabbit IgG antibody was used to detect the primary antibody.")
![<b>Genetic Strategies Validation. </b>Western Blot: BMPR-II Antibody [NBP1-32218] - Various whole cell extracts (30 ug) were separated by 5% SDS-PAGE, and the membrane was blotted with BMPR2 antibody [C1C3] diluted at 1:500. The HRP-conjugated anti-rabbit IgG antibody (NBP2-19301) was used to detect the primary antibody.](http://images.novusbio.com/fullsize/BMPR-II-Antibody-Western-Blot-NBP1-32218-img0002.jpg)
![Western Blot: Rabbit Polyclonal BMPR-II Antibody [NBP1-32218] - Bone lysate homogenate from goats. SDS-PAGE with 0.3 mg of total protein from the homogenate per well. BMP-2, NBP1-32218, was used at a dilution of 1:1000 and RUNX/CBFA1, NBP2-24755 was used at a dilution of 1:1000 in TBS Tween and 5% powdered milk. The protein was labeled at 150 kDa. Quantification of BMP-2 in bone graft in the tibia of intrailiac cellularized goats at different times compared with tibial autograft and untreated bone defect. Evaluation of pre-cellularized graft in the iliac crest in the treatment of bone defects in the tibia of goats. G1: cellularized graft for 4 weeks applied to the tibial bone defect, G2: cellularized graft for 6 weeks applied to the tibial bone defect, G3: cellularized graft for 8 weeks applied to the tibial bone defect, G4: tibial autograft and G5: untreated bone defect. All groups were evaluated 120 days after graft implantation. Image from a verified customer review.](http://images.novusbio.com/fullsize/antibody/nbp1-32218_rabbit-polyclonal-bmpr-ii-antibody-western-blot-2952025142537..jpg)
![Western Blot: Activin RIA/ALK-2/Activin Receptor Type 1 Antibody [NB100-56432] - Analysis of Activin RIA/ALK-2/Activin Receptor Type 1 in mouse kidney lysate using this antibody at 5 ug/ml](http://images.novusbio.com/fullsize/Activin-RIA-ALK-2-Activin-Receptor-Type-1-Antibody-Western-Blot-NB100-56432-img0003.jpg "Western Blot: Activin RIA/ALK-2/Activin Receptor Type 1 Antibody [NB100-56432] - Analysis of Activin RIA/ALK-2/Activin Receptor Type 1 in mouse kidney lysate using this antibody at 5 ug/ml")
![Immunocytochemistry/Immunofluorescence: STK25 Antibody [NBP1-32670] - Analysis of methanol-fixed HeLa, using antibody at 1:200 dilution.](http://images.novusbio.com/fullsize/STK25-Antibody-Immunocytochemistry-Immunofluorescence-NBP1-32670-img0003.jpg "Immunocytochemistry/Immunofluorescence: STK25 Antibody [NBP1-32670] - Analysis of methanol-fixed HeLa, using antibody at 1:200 dilution.")
![Immunohistochemistry-Paraffin: STK25 Antibody [NBP1-32670] - Paraffin-embedded NCIN87 xenograft, using antibody at 1:100 dilution.](http://images.novusbio.com/fullsize/STK25-Antibody-Immunohistochemistry-Paraffin-NBP1-32670-img0004.jpg)
![Western Blot: STK25 Antibody [NBP1-32670] -Various whole cell extracts (30 μg) were separated by 10% SDS-PAGE, and the membrane was blotted with STK25 antibody [N1C1] diluted at 1:1000. The HRP-conjugated anti-rabbit IgG antibody (NBP2-19301) was used to detect the primary antibody.](http://images.novusbio.com/fullsize/antibody/nbp1-32670_rabbit-polyclonal-stk25-antibody-western-blot-201220247125..png)
![Immunohistochemistry: CD44 Antibody (19H12) [NBP3-26680] - Image of CD44 Antibody (19H12) diluted at 1:50 and staining in paraffin-embedded human rectal cancer performed. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4C overnight. The primary is detected by a Goat anti-rabbit polymer IgG labeled by HRP and visualized using 0.51% DAB.](http://images.novusbio.com/fullsize/nbp3-26680_rabbit-cd44-mab-19h12-2622024152247.jpg "Immunohistochemistry: CD44 Antibody (19H12) [NBP3-26680] - Image of CD44 Antibody (19H12) diluted at 1:50 and staining in paraffin-embedded human rectal cancer performed. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4C overnight. The primary is detected by a Goat anti-rabbit polymer IgG labeled by HRP and visualized using 0.51% DAB.")
![Immunohistochemistry: CD44 Antibody (19H12) [NBP3-26680] - Image of CD44 Antibody (19H12) diluted at 1:50 and staining in paraffin-embedded human rectal cancer performed. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4C overnight. The primary is detected by a Goat anti-rabbit polymer IgG labeled by HRP and visualized using 0.51% DAB.](http://images.novusbio.com/fullsize/nbp3-26680_rabbit-cd44-mab-19h12-262202415253312.jpg)
![Western Blot: CD44 Antibody (19H12) [NBP3-26680] - Positive Western Blot detected in: A549 whole cell lysate, MCF7 whole cell lysate, HepG2 whole cell lysate. All lanes: CD44 Antibody at 1: 1000 Secondary: Goat polyclonal to rabbit IgG at 1/50000 dilution. Predicted band size: 81 kDa Observed band size: 81 kDa](http://images.novusbio.com/fullsize/nbp3-26680_rabbit-cd44-mab-19h12-28220241136303.jpg)
![Immunocytochemistry/Immunofluorescence: CD44 Antibody (19H12) [NBP3-26680] - Staining of Hela with CD44 Antibody (19H12) at 1:25, counter-stained with DAPI. The cells were fixed in 4% formaldehyde and blocked in 10% normal Goat Serum. The cells were then incubated with the antibody overnight at 4C. The secondary antibody was Alexa Fluor 515-conjugated Goat Anti-Rabbit IgG (H+L).](http://images.novusbio.com/fullsize/nbp3-26680_rabbit-cd44-mab-19h12-28220241323630.jpg)
![Flow Cytometry: CD44 Antibody (19H12) [NBP3-26680] - Overlay Peak curve showing Hela cells stained with CD44 Antibody (19H12) (red line) at 1:50. The cells were fixed in 4% formaldehyde and permeated by 0.2% Triton X-100. Then 10% normal goat serum to block non-specific protein-protein interactions followed by the antibody (1ug/1*10^6 cells) for 45min at 4C. The secondary antibody used was FITC-conjugated Goat Anti-rabbit IgG (H+L) at 1:200 dilution for 35min at 4C. Control antibody (green line) was rabbit IgG (1ug/1*10^6 cells) used under the same conditions. Acquisition of >10,000 events was performed.](http://images.novusbio.com/fullsize/nbp3-26680_rabbit-cd44-mab-19h12-282202414312756.jpg)
![Immunohistochemistry-Paraffin: p70 S6 Kinase/S6K [p Ser411] Antibody [NB100-82120] - Immunohistochemical analysis in paraffin-embedded human breast carcinoma tissue using NB100-82120 (left) or the same antibody preincubated with blocking peptide(right).](http://images.novusbio.com/fullsize/p70-S6-Kinase-S6K-[p-Ser411]-Antibody-Immunohistochemistry-NB100-82120-img0006.jpg "Immunohistochemistry-Paraffin: p70 S6 Kinase/S6K [p Ser411] Antibody [NB100-82120] - Immunohistochemical analysis in paraffin-embedded human breast carcinoma tissue using NB100-82120 (left) or the same antibody preincubated with blocking peptide(right).")
![<b>Biological Strategies Validation. </b>Western Blot: p70 S6 Kinase/S6K [p Ser411] Antibody [NB100-82120] - Analysis of extracts from MCF cells untreated or treated with EGF using NB100-82120](http://images.novusbio.com/fullsize/p70-S6-Kinase-S6K-[p-Ser411]-Antibody-Western-Blot-NB100-82120-img0007.jpg)
![Immunocytochemistry/Immunofluorescence: p70 S6 Kinase/S6K [p Ser411] Antibody [NB100-82120] - Staining of methanol-fixed MCF7 cells using NB100-82120.](http://images.novusbio.com/fullsize/nb100-82120_rabbit-polyclonal-p70-s6-kinase-s6k-p-ser411-antibody-11320251555919.jpg)
![Western Blot: p38 alpha [p Tyr182] Antibody [NB100-82097] - Human breast cancer cell line MDA-MB-231 was treated with different doses of p38 inhibitor and the expression of phospho-p38 and total p38 were detected by Western blot. Image from verified customer review.](http://images.novusbio.com/fullsize/p38-alpha-[p-Tyr182]-Antibody-Western-Blot-NB100-82097-img0008.jpg "<b>Biological Strategies Validation. </b>Western Blot: p38 alpha [p Tyr182] Antibody [NB100-82097] - Human breast cancer cell line MDA-MB-231 was treated with different doses of p38 inhibitor and the expression of phospho-p38 and total p38 were detected by Western blot. Image from verified customer review.")
![<b>Biological Strategies Validation. </b>Western Blot: p38 alpha [p Tyr182] Antibody [NB100-82097] - Analysis of extracts from Hela cells untreated or treated with UV for the indicated times, using P38 MAPK (Phospho-Tyr182) antibody.](http://images.novusbio.com/fullsize/p38-alpha-[p-Tyr182]-Antibody-Western-Blot-NB100-82097-img0001.jpg)
![<b>Biological Strategies Validation. </b>Western Blot: p38 alpha [p Tyr182] Antibody [NB100-82097] - Analysis of extracts from Hela cells, treated with TNFa or calf intestinal phosphatase (CIP).](http://images.novusbio.com/fullsize/p38-alpha-[p-Tyr182]-Antibody-Western-Blot-NB100-82097-img0005.jpg)
![Immunohistochemistry-Paraffin: p38 alpha [p Tyr182] Antibody [NB100-82097] - Analysis of paraffin-embedded human breast carcinoma tissue, using NB100-82097(left) or the same antibody preincubated with blocking peptide(right).](http://images.novusbio.com/fullsize/nb100-82097_rabbit-polyclonal-p38-alpha-p-tyr182-antibody-10320252332107.jpg)
![Western Blot: TrkC [p Tyr820] Antibody [NBP1-03448] - Rat brain lysate using Rabbit antibody to phospho Y820 TrkC: whole serum at 1:1000 dilution incubated overnight at 4 degrees C. A single band will be detected. Pre-absorption of the antibody with the immunising peptide completely abolishes the detected band.](http://images.novusbio.com/fullsize/TrkC-[p-Tyr820]-Antibody-Western-Blot-NBP1-03448-img0002.jpg "Western Blot: TrkC [p Tyr820] Antibody [NBP1-03448] - Rat brain lysate using Rabbit antibody to phospho Y820 TrkC: whole serum at 1:1000 dilution incubated overnight at 4 degrees C. A single band will be detected. Pre-absorption of the antibody with the immunising peptide completely abolishes the detected band.")
![Western Blot: PKC theta [p Ser676] Antibody [NB100-82145] - Analysis of extracts from PC12 cells, treated with PMA or calf intestinal phosphatase (CIP), usingPKC theta [p Ser676] Antibody.](http://images.novusbio.com/fullsize/PKC-theta-[p-Ser676]-Antibody-Western-Blot-NB100-82145-img0007.jpg "<b>Biological Strategies Validation. </b>Western Blot: PKC theta [p Ser676] Antibody [NB100-82145] - Analysis of extracts from PC12 cells, treated with PMA or calf intestinal phosphatase (CIP), usingPKC theta [p Ser676] Antibody.")
![<b>Biological Strategies Validation. </b>Immunocytochemistry/Immunofluorescence: PKC theta [p Ser676] Antibody [NB100-82145] - Staining of methanol-fixed Hela cells using NB100-82145](http://images.novusbio.com/fullsize/PKC-theta-[p-Ser676]-Antibody-Immunocytochemistry-Immunofluorescence-NB100-82145-img0001.jpg)
![<b>Biological Strategies Validation. </b>Western Blot: PKC theta [p Ser676] Antibody [NB100-82145] - analysis of extracts from PC12 cells untreated or treated with PMA using PKC theta (Phospho-Ser676) Antibody.](http://images.novusbio.com/fullsize/PKC-theta-[p-Ser676]-Antibody-Western-Blot-NB100-82145-img0004.jpg)
![Immunohistochemistry-Paraffin: PKC theta [p Ser676] Antibody [NB100-82145] - Staining of human lung carcinoma tissue, using NB100-82145(left) or the same antibody preincubated with blocking peptide(right).](http://images.novusbio.com/fullsize/nb100-82145_rabbit-polyclonal-pkc-theta-p-ser676-antibody-103202523321014.jpg)
![Western Blot: JNK1/2/3 [p Thr 183] Antibody (SR1788) [NBP3-21529] - Western blot analysis using NBP3-21529 in NIH/3T3 cell lysate treated with Anisomycin.](http://images.novusbio.com/fullsize/nbp3-21529_rabbit-jnk1-2-3-p-thr-183-mab-sr1788-572023156479.jpg "Western Blot: JNK1/2/3 [p Thr 183] Antibody (SR1788) [NBP3-21529] - Western blot analysis using NBP3-21529 in NIH/3T3 cell lysate treated with Anisomycin.")
![Immunohistochemistry: JNK1/2/3 [p Thr 183] Antibody (SR1788) [NBP3-21529] - Immunohistochemical analysis of paraffin-embedded human breast, using NBP3-21529.](http://images.novusbio.com/fullsize/nbp3-21529_rabbit-jnk1-2-3-p-thr-183-mab-sr1788-5720231558484.jpg)
![Immunocytochemistry/Immunofluorescence: JNK1/2/3 [p Thr 183] Antibody (SR1788) [NBP3-21529] - Immunofluorescent analysis of NIH/3T3 cells treated with Anisomycin, using NBP3-21529.](http://images.novusbio.com/fullsize/nbp3-21529_rabbit-jnk1-2-3-p-thr-183-mab-sr1788-6720231051264.jpg)